PUBLIC COMPANY
save$LGVNLongeveron Inc.
$LGVNMiami, FL, USupdated 21d ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.
- phase1Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)
- phase2Lomecel-B Effects on Alzheimer's Disease
- phase2Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)
Insider activity
source: SEC Form 4routine RSU / option mechanics (6)
- Apr 1, 26tax coverAgafonova Nataliya · Chief Medical Officer13,145 sh
- Apr 1, 26tax coverLocklear Lisa · Chief Financial Officer13,145 sh
- Apr 1, 26tax coverBlass Devin · CTO & SVP of CMC8,633 sh
- Apr 1, 26tax coverLehr Paul T · General Counsel, Secretary5,611 sh
- Apr 1, 26tax coverWillard Stephen H · Chief Executive Officer4,740 sh
- Mar 2, 26tax coverWillard Stephen H · Chief Executive Officer105,533 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 8m ago
Found something off?
comments(0)
5-min edit window · permanent after that